Enfusion

Enfusion P/CF

Delisted

The P/CF (Price-to-Cash-Flow Ratio) of Enfusion (ENFN) as of Nov 7, 2026 is 40.28. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 54.50 — a change of -26.09% (lower).

P/CF

40.28

YoY

-26.09%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Enfusion is 2024 40.28 . P/CF (Price-to-Cash-Flow Ratio) of Enfusion was 2023 54.50 . It decreases by -26.09% lower compared to the previous year.

The Enfusion P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2019
113.53 USD
Jan 1, 2020
839.14 USD
Jan 1, 2021
-4,393.58 USD
Jan 1, 2022
98.70 USD
Jan 1, 2023
54.50 USD
Jan 1, 2024
40.28 USD
The Enfusion P/CF history
YEARP/CFYoY
40.28-26.09%
54.50-44.78%
98.70-102.25%
-4,393.58-623.58%
839.14+639.10%
113.53—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

P/CF (Price-to-Cash-Flow Ratio) of Enfusion is 40.28 in 2024.

P/CF (Price-to-Cash-Flow Ratio) of Enfusion changed from 54.50 to 40.28, representing a -26.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Enfusion since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Enfusion with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Enfusion

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Enfusion